Related content

Losartan hydroxylation phenotype in an Ecuadorian population: influence of CYP2C9 genetic polymorphism, habits and gender

By Dorado Pedro   Beltrán Leonardo J   Machín Esther   Peñas-LLedó Eva M   Terán Enrique   LLerena Adrián  

Pharmacogenomics, Vol. 13, Iss. 15, 2012-11 ,pp. : 1711-1717

Future Medicine

Access to resources Recommend Favorite

CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patients

By Klen Jasna   Dolžan Vita   Janež Andrej  

European Journal of Clinical Pharmacology, Vol. 70, Iss. 4, 2014-04 ,pp. : 421-428

Springer Publishing Company

Access to resources Recommend Favorite

Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity

By Dandara Collet   Lombard Zané   Du Plooy Ingrid   McLellan Tracy   Norris Shane A   Ramsay Michèle  

Pharmacogenomics, Vol. 12, Iss. 12, 2011-12 ,pp. : 1663-1670

Future Medicine

Access to resources Recommend Favorite

Characterization of the most common CYP2C9 and CYP2C19 allelic variants in the population from the Republic of Macedonia

By Jakovski K.   Nestorovska A. Kapedanovska   Labacevski N.   Dimovski A.J.  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 11, 2013-11 ,pp. : 893-898

Govi-Verlag

Access to resources Recommend Favorite

Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans

By Ghotbi Roza   Christensen Magnus   Roh Hyung-Keun   Ingelman-Sundberg Magnus   Aklillu Eleni   Bertilsson Leif  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 6, 2007-06 ,pp. : 537-546

Springer Publishing Company

Access to resources Recommend Favorite